Ozempic Weight Loss Results in Adults Over 65 The introduction of semaglutide, marketed as Ozempic for type 2 diabetes treatment and Wegovy for weight loss, has brought significant attention to the realm of GLP 1 receptor agonists.
This class of medications works by mimicking the action of glucagon like peptide 1 (GLP 1), a hormone that regulates appetite and glucose metabolism. For adults over 65, Ozempic offers a novel approach to weight loss.
Understanding Ozempic's Mechanism for Weight Loss in Adults Over 65 Ozempic works by inhibiting dipeptidyl peptidase 4 (DPP 4), an enzyme that breaks down GLP 1.